Primary tabs
The list of publications is indicative and may not include all publications.
Successful Outcome of Severe Intra-cerebral Bleeding Associated with Acquired Factor V Inhibition: Utilization of Multiple Therapeutic Agents..
Balkan Med J. 35(1), 112-115.
(2018).
Hepatitis C infection in a Greek population with inherited bleeding disorders..
Haemophilia. 24(2), e74-e76.
(2018).
Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomas..
Histol Histopathol. 32(8), 825-834.
(2017).
Rivaroxaban Use in Patients with Hemoglobinopathies..
Hemoglobin. 41(3), 223-224.
(2017).
Haemophilia and low bone mass. Ok, but what about fracture risk?.
Haemophilia. 22(1), 11-4.
(2016).
Understanding cardiovascular risk in hemophilia: A step towards prevention and management..
Thromb Res. 140, 14-21.
(2016).
The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?.
Turk J Haematol. 33(2), 88-93.
(2016).
Evaluation of Mental Health and Physical Pain in Patients with β-Thalassemia Major in Northern Greece..
Hemoglobin. 39(3), 169-72.
(2015).
Successful Treatment of Severe Anemia using Erythropoietin in a Jehovah Witness with Non-Hodgkin Lymphoma..
Hematol Rep. 6(4), 5600.
(2014).
Laboratory investigation of platelet function in patients with thalassaemia..
Acta Haematol. 132(1), 45-8.
(2014).
The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B..
Haemophilia. 20(2), 268-75.
(2014).
The role of arthropathy in the development of osteoporosis in patients with haemophilia: do we need more?.
Haemophilia. 20(1), e83-5.
(2014).
Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine..
Blood Cancer J. 4, e187.
(2014).
Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis..
Osteoporos Int. 25(10), 2399-407.
(2014).
Blastic plasmacytoid dendritic cell neoplasm: single-center experience with two cases in one year..
Turk J Haematol. 31(4), 422-3.
(2014).
Bone disease in patients with haemophilia. What is true?.
Eur J Haematol. 90(5), 434.
(2013).
Vitamin D deficiency in patients with haemophilia: an underestimated commorbidity..
Haemophilia. 19(5), e308-10.
(2013).
The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture..
Thromb Haemost. 110(2), 257-63.
(2013).
Is there any association between leptin levels and bone mineral density in haemophiliac men?.
Arch Med Sci. 9(3), 459-65.
(2013).
Reduced bone mineral density in patients with haemophilia A and B in Northern Greece..
Thromb Haemost. 107(3), 545-51.
(2012).
Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival..
Hepatol Res. 40(2), 161-70.
(2010).
Late onset ulcerative colitis complicating a patient with Budd-Chiari syndrome: a case report and review of the literature..
Eur J Gastroenterol Hepatol. 21(1), 109-13.
(2009).
Hypoglycemia in a patient with advanced Sezary syndrome..
Leuk Lymphoma. 50(2), 284-6.
(2009).
Pregnancy in a patient with severe factor X deficiency..
Haemophilia. 15(6), 1351-3.
(2009).